// App-Quantinova.ai

GW25-e4500 : Tailored anti-platelet treatment guided by the platelet function assays reduces the major cardiac events in patients undergoing percutaneous coronary intervention: a meta- analysis of randomized controlled trials

Researchers

Presenter

  • Xu Lei

Principal Investigators

  • Chunjian Li

Medical Centers

  • First Affiliated Hospital of Anhui Medical University, Hefei, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • Alpha-tubulin N-acetyltransferase 1

  • Catalase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved